Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Tvardi Therapeutics, Inc. | StockGist | StockGist

Companies
TVRD
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings TVRDSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Tvardi Therapeutics, Inc.

Filed Feb 17, 2026

Accepted Feb 16, 2026, 7:00 PM ET

CIK 0001346830

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

422,555

Reporting Person

Tvardi Therapeutics, Inc.

Person Type

IN

CUSIP: 140755307

Amendment History

3 filings

SCHEDULE 13G
Original
Aug 14, 20250000902664-25-003656
SCHEDULE 13G/A
Amendment 1
Aug 5, 20250001415889-25-021104
SCHEDULE 13G/A
Amendment 2
Latest
Viewing
Feb 17, 20260001486420-26-000003

Key Facts

Shares Owned

422,555

Recent Filings

Tvardi Therapeutics, Inc.4 days ago

Tvardi Therapeutics, Inc.4 days ago

Tvardi Therapeutics, Inc.4 weeks ago

Tvardi Therapeutics, Inc.2 months ago

Tvardi Therapeutics, Inc.3 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice